Journal of Genetics

, 98:21 | Cite as

Novel mutation in Cul7 gene in a family diagnosed with 3M syndrome

  • Shagufta Shaikh
  • Suresh K. G. ShettigarEmail author
  • Santosh Kumar
  • Surita Kantharia
  • Jagannath Kurva
  • Susan Cherian
Research Note


This study evaluates a family with two siblings having severe growth retardation and facial dysmorphism, born to consanguineous normal healthy parents. Affymetrix CytoScan 750K microarray showed a 34-Mb pericentric homozygous region on chromosome 6 for both siblings. CUL7 was one of the 141 genes present in this region. Sanger sequencing of CUL7 gene detected a 2-bp novel deletion in the 15th exon (c.2943_2944delCT of the cDNA). This deletion leads to a frameshift and a premature termination signal much upstream of the wild-type termination signal, leading to a nonsense mediated decay of the mRNA. CUL7 protein plays an important role in formation of 3M complex, ubiquitination, microtubule dynamics and cell cycle regulation. Mutations in CUL7 gene is known to cause a rare 3M syndrome. Information about the novel mutation has been accepted in the ClinVar database with rs1064792895.


3M syndrome ubiquitination proteasomal degradation skeletal dysplasia consanguinity 



We thank Dr M. Seshadri former Head, RBHSD; Dr Sangeeta S., pediatrician BARC Hospital and Mr Raut, M.Sc. student.

Supplementary material

12041_2019_1057_MOESM1_ESM.docx (1.1 mb)
Supplementary material 1 (docx 1109 KB)
12041_2019_1057_MOESM2_ESM.docx (1.1 mb)
Supplementary material 2 (docx 1114 KB)


  1. Brogna S. and Wen J. 2009 Nonsense-mediated mRNA decay (NMD) mechanisms. Nat. Struct. Mol. Biol. 16, 107–113.CrossRefGoogle Scholar
  2. Clayton P. E., Hanson D., Magee L., Murray P. G., Saunders E., Abu-Amero S. N. et al. 2012 Exploring the spectrum of 3-M syndrome, a primordial short stature disorder of disrupted ubiquitination. Clin. Endocrinol. (Oxf.) 77, 335–342.CrossRefGoogle Scholar
  3. Deeb A., Afandi O., Attia S. and El Fatih A. 2015 3-M syndrome: a novel CUL7 mutation associated with respiratory distress and a good response to GH therapy. Endocrinol. Diabetes Metab. Case Rep. 2015, 150012.PubMedPubMedCentralGoogle Scholar
  4. Hanson D., Murray P. G., Sud A., Temtamy S. A., Aglan M., Superti-Furga A. et al. 2009 The primordial growth disorder 3-M syndrome connects ubiquitination to the cytoskeletal adaptor OBSL1. Am. J. Hum. Genet. 84, 801–806.CrossRefGoogle Scholar
  5. Hanson D., Murray P. G., Black G. C. M. and Clayton P. E. 2011a The genetics of 3-M syndrome: unravelling a potential new regulatory growth pathway. Horm. Res. Paediatr. 76, 369–378.CrossRefGoogle Scholar
  6. Hanson D., Murray P. G., O’Sullivan J., Urquhart J., Daly S., Bhaskar S. S. et al. 2011b Exome sequencing identifies CCDC8 mutations in 3-M syndrome, suggesting that CCDC8 contributes in a pathway with CUL7 and OBSL1 to control human growth. Am. J. Hum. Genet. 89, 148–153.CrossRefGoogle Scholar
  7. Hanson D., Murray P. G., Coulson T., Sud A., Omokanye A., Stratta E. et al. 2012 Mutations in CUL7, OBSL1 and CCDC8 in 3-M syndrome lead to disordered growth factor signalling. J. Mol. Endocrinol. 49, 267–275.CrossRefGoogle Scholar
  8. Hug N., Longman D. and Caceres J. F. 2016 Mechanism and regulation of the nonsense-mediated decay pathway. Nucleic Acids Res.  44, 1483–1495.CrossRefGoogle Scholar
  9. Kirin M., McQuillan R., Franklin C. S., Campbell H., McKeigue P. M. and Wilson J. F. 2010 Genomic runs of homozygosity record population history and consanguinity. PLoS One 5, e13996.CrossRefGoogle Scholar
  10. Lugli L., Bertucci E., Mazza V., Elmakky A., Ferrari F., Neuhaus C. et al. 2016 Pre- and post-natal growth in two sisters with 3-M syndrome. Eur. J. Med. Genet. 59, 232–236.CrossRefGoogle Scholar
  11. Lykke-Andersen S. and Jensen T. H. 2015 Nonsense-mediated mRNA decay: an intricate machinery that shapes transcriptomes. Nat. Rev. Mol. Cell Biol. 16, 665–677.CrossRefGoogle Scholar
  12. Maksimova N., Hara K., Miyashia A., Nikolaeva I., Shiga A., Nogovicina A. et al. 2007 Clinical, molecular and histopathological features of short stature syndrome with novel CUL7 mutation in Yakuts: new population isolate in Asia. J. Med. Genet. 44, 772–778.CrossRefGoogle Scholar
  13. Meazza C., Lausch E., Pagani S., Bozzola E., Calcaterra V., Superti-Furga A. et al. 2013 3-M syndrome associated with growth hormone deficiency: 18 year follow-up of a patient. Ital. J. Pediatr. 39, 21.CrossRefGoogle Scholar
  14. Nampoothiri S., Yesodharan D., Sainulabdin G., Narayanan D., Padmanabhan L., Girisha K. M. et al. 2014 Eight years experience from a skeletal dysplasia referral center in a tertiary hospital in Southern India: a model for the diagnosis and treatment of rare diseases in a developing country. Am. J. Med. Genet. A 164A, 2317–2323.CrossRefGoogle Scholar
  15. Okonechnikov K., Golosova O. and Fursov M. 2012 Unipro UGENE: a unified bioinformatics toolkit. Bioinformatics 28, 1166–1167.CrossRefGoogle Scholar
  16. Sasaki K., Okamoto N., Kosaki K.,Yorifuji T., Shimokawa O., Mishima H. et al. 2011 Maternal uniparental isodisomy and heterodisomy on chromosome 6 encompassing a CUL7 gene mutation causing 3M syndrome. Clin. Genet. 80, 478–483.CrossRefGoogle Scholar
  17. Ye J., Coulouris G., Zaretskaya I., Cutcutache I., Rozen S. and Madden T. L. 2012 Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinform. 13, 134.CrossRefGoogle Scholar

Copyright information

© Indian Academy of Sciences 2019

Authors and Affiliations

  • Shagufta Shaikh
    • 1
  • Suresh K. G. Shettigar
    • 1
    Email author
  • Santosh Kumar
    • 2
  • Surita Kantharia
    • 3
  • Jagannath Kurva
    • 1
  • Susan Cherian
    • 1
  1. 1.Cytogenetics and Molecular Genetics Section, Pathology UnitBhabha Atomic Research Centre HospitalAnushaktinagarIndia
  2. 2.Pediatric Unit, Medical DivisionBhabha Atomic Research Centre HospitalAnushaktinagarIndia
  3. 3.Radiology Unit, Medical DivisionBhabha Atomic Research Centre HospitalAnushaktinagarIndia

Personalised recommendations